Skip to main content

Yoo-Chul Hwang

Kyung Hee University · Biochemistry, Genetics and Molecular Biology

About the Lab

Professor Yoo-Chul Hwang's research lab focuses on metabolic and cardiovascular complications in diabetes, with a particular emphasis on the pathophysiological mechanisms linking hyperglycemia, insulin resistance, and vascular dysfunction. The lab investigates the therapeutic potential of nutraceuticals such as taurine and pharmacological agents like DPP4 inhibitors and lipid-modifying therapies in improving glucose metabolism and reducing macrovascular risk. Key research directions include the role of nuclear factor-κB signaling in vascular smooth muscle cell dysfunction, the impact of environmental toxins like arsenic on diabetes risk, and the clinical utility of advanced metabolic markers such as HOMA2 and apoB/A1 ratio in predicting diabetes and cardiovascular outcomes in Korean populations.

diabetes complicationsinsulin resistancevascular dysfunctiontaurine supplementationHOMA2 model

Research Overview

Papers
24
Total Citations
248
Papers (5y)
10
Primary Field
Biochemistry, Genetics and Molecular Biology

Research Output Trend

Figures are computed from collected data and may differ slightly.

Publications per year (5y)
10total
2015
2016
2017
2018
2019
Citations per year (5y)
80total
20152016201720182019

Selected Papers

15
1
Article|61 citations·2012
Taurine ameliorates hyperglycemia and dyslipidemia by reducing insulin resistance and leptin level in Otsuka Long-Evans Tokushima fatty (OLETF) rats with long-term diabetes
김경수, Da Hee Oh, 김정연, Bong Gn Lee, Jeong Soon You, 장경자, 정현주, Myung Chul Yoo, 양형인, 강자헌, 황유철, 안규정

This study aimed to determine whether taurine supplementation improves metabolic disturbances and diabetic complications in an animal model for type 2diabetes. We investigated whether taurine has therapeutic effects on glucose metabolism, lipid metabolism,and diabetic complications in Otsuka Long-Evans Tokushima fatty (OLETF) rats with long-term duration of diabetes. Fourteen 50-week-old OLETF rats with chronic diabetes were fed a diet supplemented with taurine (2%) or a non-supplemented control

2
Article|52 citations·2011
Inhibition of NF-κB prevents high glucose-induced proliferation and plasminogen activator inhibitor-1 expression in vascular smooth muscle cells
In‐Kyung Jeong, Da Hee Oh, Seung-Joon Park, Ja-Heon Kang, Sunshin Kim, Myung‐Shik Lee, Myung-Jun Kim, Yoo-Chul Hwang, Kyu Jeung Ahn, Ho-Yeon Chung, Min-Kyung Chae, Hyung-Joon Yoo
SJR Q1Experimental & Molecular MedicineOA

Recent epidemiologic studies clearly showed that early intensive glucose control has a legacy effect for preventing diabetic macrovascular complications. However, the cellular and molecular processes by which high glucose leads to macrovascular complications are poorly understood. Vascular smooth muscle cell (VSMC) dysfunction due to high glucose is a characteristic of diabetic vascular complications. Activation of nuclear factor-κB (NF-κB) may play a key role in the regulation of inflammation a

Cancer ResearchBiochemistry, Genetics and Molecular Biology
3
Article|36 citations·2013
Arsenic Exposure and Prevalence of Diabetes Mellitus in Korean Adults
이상열, 우정택, 황유철, 신상욱, 전숙, 김영설
Journal of Korean Medical Science

It has been suggested that there is an association between environmental, low-level arsenic exposure and the risk of diabetes mellitus (DM), but little research has been conducted. Here, the glucose tolerance status and urinary creatinine adjusted total arsenic concentrations were analyzed in 3,602 subjects ≥ 20 yr of age who were registered for the Korea National Health and Nutrition Examination Survey, 2008-2009. Various demographic parameters were associated with urinary arsenic concentration

4
Article|25 citations·2016
Comparison of the Usefulness of the Updated Homeostasis Model Assessment (HOMA2) with the Original HOMA1 in the Prediction of Type 2 Diabetes Mellitus in Koreans
송영석, 황유철, 안홍엽, 박철영
Diabetes and Metabolism Journal

Background: The original homeostasis model assessment (HOMA1) and the updated HOMA model (HOMA2) have been used to evaluate insulin resistance (IR) and β-cell function, but little is known about the usefulness of HOMA2 for the prediction of diabetes in Koreans. The aim of this study was to demonstrate the usefulness of HOMA2 as a predictor of type 2 diabetes mellitus in Koreans without diabetes. Methods: The study population consisted of 104,694 Koreans enrolled at a health checkup program and f

5
Article|20 citations·2015
Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database
서성환, 서기현, 정창희, 김미경, 진상만, 황유철, 이병완, 김재현
Diabetes and Metabolism Journal

Background: We assessed the association of dipeptidyl peptidase 4 inhibitors (DPP4i) with hospitalization for heart failure (HF) using the Korean Health Insurance claims database. Methods: We collected data on newly prescribed sitagliptin, vildagliptin, and pioglitazone between January 1, 2009 and December 31, 2012 (mean follow-up of 336.8 days) to 935,519 patients with diabetes (518,614 males and 416,905 females) aged 40 to 79 years (mean age of 59.4 years). Results: During the study, 998 patie

6
Article|18 citations·2019
Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus
황유철, 전지은, 정인경, 안규정, 정호연
Diabetes and Metabolism Journal

Background: The apolipoprotein B/A1 (apoB/A1) ratio is a stronger predictor of future cardiovascular disease than is the level ofconventional lipids. Statin and ezetimibe combination therapy have shown additional cardioprotective effects over statin monotherapy. Methods: This was a single-center, randomized, open-label, active-controlled study in Korea. A total of 36 patients with type 2 diabetesmellitus were randomized to either rosuvastatin monotherapy (20 mg/day, n=20) or rosuvastatin/ezetimi

7
Article|10 citations·2012
Optimal Range of Triglyceride Values to Estimate Serum Low Density Lipoprotein Cholesterol Concentration in Korean Adults: the Korea National Health and Nutrition Examination Survey, 2009
황유철, Hong Yup Ahn, 정인경, Kyu Jeung Ahn, Ho Yeon Chung
Journal of Korean Medical Science

The aims of this study were to investigate the validity of Friedewald’s formula and to propose a range of triglyceride values over which the formula can be used without significant error. This was a cross-sectional analysis of 1,929 subjects (946 males and 983females) aged 20 yr and older using data of the Korea National Health and Nutrition Examination Survey in 2009. Estimated total number was considered to be 10,633,655(5,846,384 males and 4,787,271 females). Calculated and directly-measured

8
Article|10 citations·2019
Higher High Density Lipoprotein 2 (HDL2) to Total HDL Cholesterol Ratio Is Associated with a Lower Risk for Incident Hypertension
황유철, Wilfred Y. Fujimoto, Steven E. Kahn, Donna L. Leonetti, Edward J. Boyko
Diabetes and Metabolism Journal

Background: Recent studies have suggested that high density lipoprotein (HDL) cholesterol is inversely associated with the development of hypertension. We aimed to determine the association between different HDL cholesterol subclasses and risk of future hypertension. Methods: A total of 270 Japanese Americans (130 men, 140 women) without hypertension between the ages of 34 to 75 years were enrolled. Blood pressure was measured with a mercury sphygmomanometer, and average blood pressure was calcu

9
Article|4 citations·2010
The Changes in Early Phase Insulin Secretion in Newly Diagnosed, Drug Naive Korean Prediabetes Subjects
이상열, 김주영, 전숙, 황유철, 정인경, 오승준, 안규정, 정호연, 우정택, 김성운, 김진우, 김영설
Diabetes and Metabolism Journal

Background: There have been no systematic observations regarding changes in early phase insulin secretion among Korean prediabetes and early stage type 2 diabetes mellitus (T2DM) patients. Methods: We conducted 75-g oral glucose tolerance tests (OGTT) in 873 subjects with suspected abnormal glucose tolerance. All subjects were diagnosed as having normal glucose tolerance (NGT), prediabetes (preDM), or T2DM according to the OGTT results and the insulin secretory and insulin resistance indices of

10
Article|3 citations·2018
Predictors of Incident Type 2 Diabetes Mellitus in Japanese Americans with Normal Fasting Glucose Level
황유철, Wilfred Y. Fujimoto, Steven E. Kahn, Donna L. Leonetti, Edward J. Boyko
Diabetes and Metabolism Journal

Background: Little is known about the natural course of normal fasting glucose (NFG) in Asians and the risk factors for future diabetes. Methods: A total of 370 Japanese Americans (163 men, 207 women) with NFG levels and no history of diabetes, aged 34 to 75 years, were enrolled. Oral glucose tolerance tests were performed at baseline, 2.5, 5, and 10 years after enrollment. Results: During 10 years of follow-up, 16.1% of participants met criteria for diabetes diagnosis, and 39.6% of subjects sti

11
Article|2 citations·2015
Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database (Diabetes Metab J 2015;39:247-52)
서성환, 서기현, 정창희, 김미경, 진상만, 황유철, 이병완, 김재현
Diabetes and Metabolism Journal
12
Article|2 citations·2001
단백뇨를 가진 IgA 신증 환자들에서 안지오텐신 II 수용체 길항제의 효과
노정현, 황유철, 이태원, 임천규

IgA 신증에서 면역억제제 등의 치료가 효과적인지는 아직 불확실하다. 한편, ACE 억제제가 신질환 환자들에서 단백뇨량을 감소시키는 것으로 알려져 있다. 이에 안지오텐신 II 수용체 길항제인 로잘탄의 단백뇨를 가진 특발성 IgA 신증 환자들에서의 단백뇨와 신기능에 대한 치료효과를 1-4개월간의 단기간 및 7-13개월간의 전향적 추적관찰 후 알아보고자 하였다. 총 12명의 단백뇨을 가진 IgA 신증 환자군에서 50mg 또는 100mg 복용 후 1-4개월 후 24시간 단백뇨는 투여 전 2.8±1.1g에서 투여 후 1-4개월 뒤에 1.1±1.0g으로 유의하게 감소하였다. 7-13개월 후에 단백뇨는 1.7±0.6g으로 감소되어 있었다. 로잘탄 복용에 의한 심각한 부작용은 관찰되지 않았으며 특히 기침이나 혈관 부종 등은 없었다. 혈청 크레아티닌은 로잘탄 복용 전후로 유의한 변화가 없었다. 결론적으로 대부분의 IgA신증 환자들에서 안지오텐신 II수용체 길항제는 큰 부작용 없이 단백뇨에 유익한

13
Article|2 citations·2017
Validation of a Newly Developed Equation for Estimating Serum Apolipoprotein B: Associations with Cardiovascular Disease Surrogate Markers in Koreans
김종대, 안홍엽, 황유철, 박철영
https://www.eymj.org/DOIx.php?id=10.3349/ymj.2017.58.5.975

Purpose: Many clinical guidelines recommend apolipoprotein B (apoB) measurement, particularly in subjects with metabolic syndrome or type 2 diabetes. Recently, we developed a new equation to estimate serum apoB (apoBE). We validated the clinical relevance of apoBE and compared the performance of the equation with conventional lipid measurements and direct measurementof apoB. Materials and Methods: Study subjects were recruited from patients who visited the Health Screening Center at Kangbuk Sams

14
Article|1 citations·2011
코르티졸, 안드로겐, 알도스테론을 동시에 분비하는 부신피질암 1예
최재호, 소예리, 황유철, 정인경, 안규정, 정호연, 양승애

Primary adrenocortical carcinoma is a rare tumor, and is characterized by a peri-tumor mass effect and hormone excess signs. Adrenocortical carcinoma most commonly secretes cortisol, but tumors that secrete other adrenal hormones (aldosterone, androgen)are rare. Herein, we report the case of a 70-year-old woman with cortisol, androgen, and aldosterone-secreting adrenal carcinoma. The patient complained of generalized weakness, moon face, and central obesity. On laboratory examination, hypokalemi

15
Article|1 citations·2011
후천성 면역결핍증 환자에서 발현된 일차성 부신기능부전 1예
최재호, 전숙, 황유철, 손준성, 오승준, 안규정, 정호연, 우정택, 김성운, 김진우, 김영설, 정인경

The adrenal gland is the most commonly involved endocrine organ in patients infected with the human immunodeficiency virus (HIV). Adrenal function abnormality is more common in HIV patients than in the general population. It is important to recognize the condition of adrenal insufficiency, as this adrenal disorder may prove fatal if left untreated. Herein, we report a case of primary adrenal insufficiency in a 37-year-old male patient with acquired immunodeficiency syndrome. The patient complain

Research Areas

Cancer Research

Dive deeper into Yoo-Chul Hwang's research on Nubint

Open this lab's papers in the app to read with AI, summarize, and cite in your writing.